FR2359120B1 - - Google Patents

Info

Publication number
FR2359120B1
FR2359120B1 FR7722097A FR7722097A FR2359120B1 FR 2359120 B1 FR2359120 B1 FR 2359120B1 FR 7722097 A FR7722097 A FR 7722097A FR 7722097 A FR7722097 A FR 7722097A FR 2359120 B1 FR2359120 B1 FR 2359120B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7722097A
Other versions
FR2359120A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH920776A external-priority patent/CH622495A5/de
Priority claimed from CH921076A external-priority patent/CH622496A5/de
Priority claimed from CH920976A external-priority patent/CH622244A5/de
Priority claimed from CH1206576A external-priority patent/CH623565A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2359120A1 publication Critical patent/FR2359120A1/fr
Application granted granted Critical
Publication of FR2359120B1 publication Critical patent/FR2359120B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
FR7722097A 1976-07-19 1977-07-19 Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments Granted FR2359120A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH920776A CH622495A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH921076A CH622496A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH920976A CH622244A5 (en) 1976-07-19 1976-07-19 Process for the preparation of novel polypeptide derivatives
CH1206576A CH623565A5 (en) 1976-09-23 1976-09-23 Process for the preparation of polypeptide derivatives

Publications (2)

Publication Number Publication Date
FR2359120A1 FR2359120A1 (fr) 1978-02-17
FR2359120B1 true FR2359120B1 (fr) 1980-01-18

Family

ID=27429201

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7722097A Granted FR2359120A1 (fr) 1976-07-19 1977-07-19 Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments

Country Status (6)

Country Link
JP (1) JPS5312839A (fr)
BE (1) BE856899A (fr)
DE (1) DE2730851A1 (fr)
FR (1) FR2359120A1 (fr)
GB (1) GB1587427A (fr)
NL (1) NL7707894A (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH637626A5 (en) * 1976-11-23 1983-08-15 Wellcome Found Process for the preparation of peptides
DE2819277A1 (de) * 1977-05-16 1978-11-23 Sandoz Ag Neue polypeptidderivate, ihre herstellung und verwendung
HU182051B (en) * 1978-05-02 1983-12-28 Takeda Chemical Industries Ltd Process for preparing tetrapeptide-hydrazyde derivatives
US4277394A (en) * 1979-04-23 1981-07-07 Takeda Chemical Industries, Ltd Tetrapeptidehydrazide derivatives
DE2941790A1 (de) * 1979-10-16 1981-04-30 Hoechst Ag, 6000 Frankfurt Verwendung motilitaetssteigernder peptide
SU1460965A1 (ru) * 1987-06-19 1991-10-15 Всесоюзный кардиологический научный центр АМН СССР Гексапептид, обладающий противо звенным действием
NZ233071A (en) * 1989-03-30 1993-02-25 Sumitomo Pharma Neurotrophic peptides, extraction from mammalian hippocampal tissue and pharmaceutical compositions thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ183712A (en) * 1976-04-08 1979-10-25 Ici Ltd Polypeptide analogues of enkephalins, and pharmaceutical compositions

Also Published As

Publication number Publication date
GB1587427A (en) 1981-04-01
JPS5312839A (en) 1978-02-04
DE2730851A1 (de) 1978-01-26
BE856899A (fr) 1978-01-18
FR2359120A1 (fr) 1978-02-17
NL7707894A (nl) 1978-01-23

Similar Documents

Publication Publication Date Title
FR2364890B1 (fr)
FR2359120B1 (fr)
JPS5749053B2 (fr)
JPS5356780U (fr)
FR2371422B1 (fr)
JPS5647376Y2 (fr)
JPS5439959Y2 (fr)
JPS5541375Y2 (fr)
JPS5615373Y2 (fr)
JPS5715293Y2 (fr)
JPS5390035U (fr)
JPS52136149U (fr)
JPS52170429U (fr)
JPS5335006U (fr)
CU34413A (fr)
CS177399B1 (fr)
JPS5370092U (fr)
CS176987B1 (fr)
JPS5385041U (fr)
JPS52140666U (fr)
CH604402A5 (fr)
CH599541A5 (fr)
LU74988A1 (fr)
CH602581A5 (fr)
CH606749A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse